Back to Journals » Cancer Management and Research » Volume 11

CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer

Total article views   HTML views PDF downloads Totals
5,259 Dovepress* 4,348+ 931 5,279
PubMed Central* 911 192 1,103
Totals 5,259 1,123 6,382
*Since 15 April 2019

View citations on PubMed Central and Google Scholar